title: Myoma uterus as a marker of oncogynecological pathology in pre- and post-menopause.
abstract: Development and (or) growth of myoma uteri in pre- and post-menopause is accompanied by hyperestrogenia which is shown by histological investigation of the endometrium and the ovaries. A comparative clinical and morphological study of 853 patients with myoma uteri, 996 patients with glandular, atypical hyperplasia and endometrial carcinoma was carried out. Benign tumors of the ovaries were revealed in 9.5% of patients with myoma, 12.7% of patients with atypical endometrial hyperplasia and 19.8% of patients with endometrial cancer. A significant increase of the occurrence of endometrial cancer in postmenopausal patients with myoma, in comparison with patients in the reproductive period was determined, 13.4% and 1.1% respectively, P = 0.01. In postmenopause "growth" of the tumor was more often and significantly simulated by malignant disease of the uterus and adnexa. In postmenopausal patients with myoma and uterine bleeding, endometrial carcinoma was 5.5 times more often revealed in comparison with the analogous group of patients in the reproductive period. The "relative risk" of the development of endometrial cancer, sarcoma uteri and ovarian tumors was calculated. The "relative risk" was shown to increase in the postmenopausal period. In the processes of observation of patients with myoma in postmenopause, cytological investigation of endometrial aspirates, ultrasound and mammographic screening should be carried out.
authors.affiliation: Department of Gynecology, N. N. Petrov Research Institute of Oncology,Ministry of Health of USSR, Leningrand.
authors.forename: Y a
authors.initials: Ya
authors.lastname: Bokhman
authors.forename: V T
authors.initials: VT
authors.lastname: Tkeshelashvili
authors.forename: A S
authors.initials: AS
authors.lastname: Vishnevsky
authors.forename: A T
authors.initials: AT
authors.lastname: Volkova
mesh_terms: D000328:Adult; D000367:Age Factors; D000368:Aged; D004714:Endometrial Hyperplasia / Q000209:etiology* / Q000473:pathology; D005260:Female; D006801:Humans; D007889:Leiomyoma / Q000473:pathology*; D008593:Menopause; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000209:etiology*; D012307:Risk Factors; D014594:Uterine Neoplasms / Q000473:pathology*